Cel-Sci
CVM
#9905
Rank
NZ$67.99 M
Marketcap
NZ$8.51
Share price
-10.73%
Change (1 day)
-77.11%
Change (1 year)

Earnings for Cel-Sci (CVM)

Earnings in 2025 (TTM): -NZ$41.89 Million

According to Cel-Sci 's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -NZ$46.03 Million, an increase over its 2023 earnings that were of -NZ$52.55 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cel-Sci from 1986 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$41.89 Million-9%
2024 -NZ$46.03 Million-12.41%
2023 -NZ$52.55 Million-12.87%
2022 -NZ$60.31 Million-3.42%
2021 -NZ$62.45 Million13.44%
2020 -NZ$55.05 Million11.28%
2019 -NZ$49.47 Million179.81%
2018 -NZ$17.68 Million-48.72%
2017 -NZ$34.48 Million-16.23%
2016 -NZ$41.16 Million-23.63%
2015 -NZ$53.9 Million-5.47%
2014 -NZ$57.02 Million198.49%
2013 -NZ$19.1 Million
2010 -NZ$22.3 Million
2004 -NZ$7.54 Million12.38%
2003 -NZ$6.71 Million-16.59%
2002 -NZ$8.04 Million-59.28%
2001 -NZ$19.74 Million23.17%
2000 -NZ$16.03 Million20.12%
1999 -NZ$13.35 Million13.24%
1998 -NZ$11.79 Million-20%
1997 -NZ$14.73 Million46.55%
1996 -NZ$10.05 Million34.88%
1995 -NZ$7.45 Million2.38%
1994 -NZ$7.28 Million68%
1993 -NZ$4.34 Million78.57%
1992 -NZ$2.43 Million180%
1991 -NZ$0.87 Million25%
1990 -NZ$0.7 Million-0%
1989 -NZ$0.7 Million-71.43%
1988 -NZ$2.43 Million-0%
1987 -NZ$2.43 Million-46.15%
1986 -NZ$4.51 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Curis
CRIS
-NZ$56.41 Million 31.68%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-NZ$11.47 Million-73.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$14.28 B-33,443.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
-NZ$0.24 Billion 458.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$3.06 B-7,266.95%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Johnson & Johnson
JNJ
NZ$56.12 B-131,127.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
NZ$0.28 B-768.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-NZ$16.44 Million-61.62%๐Ÿ‡บ๐Ÿ‡ธ USA